Is Qualigen Therapeutics, Inc. (QLGN) a Buy, Sell, or Hold?
NASDAQ : QLGN
Qualigen Therapeutics, Inc. — Insider Trades
$3.21 USD
$0.17 (5.59%)
- Volume
- 368.77K
- Average Volume
- 2.65M
- Market Capitalization
- $5.43M
- P/E Ratio
- -0.51
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $8.81
- Year Low
- $1.61
- Day High
- —
- Day Low
- —
- Payout Ratio
- -$0.07
- Current Ratio
- $3.68
Insider Activity Summary (Last 12 Months)
Insiders Buying
17
Insiders Selling
0
Amount of Insider Selling
-$
QLGN Insider Buying/Selling by Quarter
QLGN Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Bensler Graydon | director: | 2024-11-07 | 0 | 2024-11-15 | |
| Braeden Lichti | director: | 2024-10-08 | 0 | 2024-10-17 | |
| LIM ROBERT BRADLEY | director: | 2024-07-12 | 0 | 2024-08-09 | |
| BECHER CAMPBELL | director: | 2024-07-12 | 0 | 2024-08-09 | |
| PRICE CODY | director: | 2024-07-12 | 0 | 2024-07-25 | |
| Abdul-Ahad Wajdi | officer: Vice President, R & D, CSO | 2022-07-11 | A-Award | 0 | 2022-08-04 |
| Lotz Christopher L. | officer: Vice President of Finance, CFO | 2022-07-11 | A-Award | 0.5136 | 2022-08-04 |
| Lotz Christopher L. | officer: Vice President of Finance, CFO | 2022-07-11 | A-Award | 0 | 2022-08-04 |
| ARSHAD TARIQ | officer: SVP/Chief Medical Officer | 2022-07-11 | A-Award | 0 | 2022-08-04 |
| Ritter Ira E. | director | 2022-07-11 | A-Award | 0.5136 | 2022-08-04 |
| Ritter Ira E. | director: | 2022-07-11 | A-Award | 0 | 2022-08-04 |
| EMERY SIDNEY W JR | director | 2022-07-11 | A-Award | 0.5136 | 2022-08-04 |
| EMERY SIDNEY W JR | director: | 2022-07-11 | A-Award | 0 | 2022-08-04 |
| Kruger Kurt H | director: | 2022-07-11 | A-Award | 0 | 2022-08-04 |
| David Richard A. | director | 2022-07-11 | A-Award | 0.5136 | 2022-08-04 |
| David Richard A. | director: | 2022-07-11 | A-Award | 0 | 2022-08-04 |
| Sinha Shishir K. | officer: VP, COO & Secretary | 2022-07-11 | A-Award | 0.5136 | 2022-08-04 |
| Sinha Shishir K. | officer: VP, COO & Secretary | 2022-07-11 | A-Award | 0 | 2022-08-04 |
| Poirier Michael S. | officer: Chairman and CEO | 2022-07-11 | A-Award | 0 | 2022-08-04 |
| Korenberg Matthew E | director: | 2022-07-11 | A-Award | 0 | 2022-08-04 |
| BROIDRICK AMY S. | director, officer: President/CSO | 2022-07-11 | A-Award | 0.5136 | 2022-08-04 |
| BROIDRICK AMY S. | officer: President/CSO | 2022-07-11 | A-Award | 0 | 2022-08-04 |
| Poirier Michael S. | officer: Chairman and CEO | 2022-06-22 | P-Purchase | 0.57 | 2022-06-22 |
| BROIDRICK AMY S. | officer: President/CSO | 2022-06-14 | P-Purchase | 0.62 | 2022-06-15 |
| BROIDRICK AMY S. | director, officer: President/ChiefStrategyOfficer | 2021-12-08 | A-Award | 1.24 | 2021-12-10 |
| ARSHAD TARIQ | officer: SVP/Chief Medical Officer | 2021-12-08 | A-Award | 1.24 | 2021-12-10 |
| Kruger Kurt H | director | 2021-08-19 | P-Purchase | 1.22 | 2021-08-20 |
| Kruger Kurt H | director | 2021-08-19 | P-Purchase | 1.23 | 2021-08-20 |
| ARSHAD TARIQ | officer: SVP/Chief Medical Officer | 2021-05-17 | A-Award | 1.8 | 2021-05-18 |
| ARSHAD TARIQ | officer | 2021-05-17 | 0 | 2021-05-17 | |
| BROIDRICK AMY S. | director, officer: EVP, Chief Strategy Officer | 2021-04-26 | P-Purchase | 2.03 | 2021-04-26 |
| Poirier Michael S. | director, officer: Chairman, CEO & President | 2021-04-20 | P-Purchase | 1.8 | 2021-04-21 |
| Lotz Christopher L. | officer: Vice President of Finance, CFO | 2021-04-16 | P-Purchase | 1.86 | 2021-04-19 |
| Kruger Kurt H | director | 2020-12-29 | P-Purchase | 2.935 | 2020-12-30 |
| BROIDRICK AMY S. | director, officer: Executive VP, CSO | 2020-12-07 | A-Award | 3.52 | 2020-12-29 |
| EMERY SIDNEY W JR | director | 2020-12-07 | A-Award | 3.52 | 2020-12-08 |
| EMERY SIDNEY W JR | director | 2020-12-07 | 0 | 2020-12-07 | |
| Kruger Kurt H | director | 2020-11-23 | P-Purchase | 3.462 | 2020-11-23 |
| Kruger Kurt H | director | 2020-11-20 | P-Purchase | 3.549 | 2020-11-23 |
| BROIDRICK AMY S. | director | 2020-08-27 | A-Award | 4.7 | 2020-08-28 |
| BROIDRICK AMY S. | director: | 2020-08-27 | 0 | 2020-08-28 | |
| SEKISUI DIAGNOSTICS, LLC | 10 percent owner: | 2020-08-04 | 0 | 2020-08-05 | |
| Ritter Ira E. | director | 2020-06-06 | A-Award | 5.13 | 2020-06-08 |
| David Richard A. | director | 2020-06-06 | A-Award | 5.13 | 2020-06-08 |
| Poirier Michael S. | director, officer: Chairman, President & CEO | 2020-06-06 | A-Award | 5.13 | 2020-06-08 |
| Abdul-Ahad Wajdi | officer: Vice President, R & D, CSO | 2020-06-06 | A-Award | 5.13 | 2020-06-08 |
| Kruger Kurt H | director | 2020-06-06 | A-Award | 5.13 | 2020-06-08 |
| Sinha Shishir K. | officer: Vice President of Operations | 2020-06-06 | A-Award | 5.13 | 2020-06-08 |
| Korenberg Matthew E | director | 2020-06-06 | A-Award | 5.13 | 2020-06-08 |
| Lotz Christopher L. | officer: Vice President of Finance, CFO | 2020-06-06 | A-Award | 5.13 | 2020-06-08 |
| SEKISUI DIAGNOSTICS, LLC | 10 percent owner | 2020-05-22 | 0 | 2020-05-27 | |
| Abdul-Ahad Wajdi | officer: VP, R&D, CSO | 2020-05-22 | J-Other | 2.5405 | 2020-05-27 |
| Abdul-Ahad Wajdi | officer: VP, R&D, CSO | 2020-05-22 | J-Other | 2.0663 | 2020-05-27 |
| Sinha Shishir K. | officer: Vice President of Operations | 2020-05-22 | J-Other | 2.0663 | 2020-05-27 |
| Sinha Shishir K. | officer: Vice President of Operations | 2020-05-22 | J-Other | 2.0663 | 2020-05-27 |
| Poirier Michael S. | director, officer: Chairman, President & CEO. | 2020-05-22 | J-Other | 0 | 2020-05-27 |
| Poirier Michael S. | director, officer: Chairman, President & CEO. | 2020-05-22 | J-Other | 2.0663 | 2020-05-27 |
| Poirier Michael S. | director, officer: Chairman, President & CEO. | 2020-05-22 | J-Other | 2.0663 | 2020-05-27 |
| Poirier Michael S. | director, officer: Chairman, President & CEO. | 2020-05-22 | J-Other | 2.5405 | 2020-05-27 |
| Poirier Michael S. | director, officer: Chairman, President & CEO. | 2020-05-22 | J-Other | 2.5405 | 2020-05-27 |
| Lotz Christopher L. | officer: VP of Finance, CFO. | 2020-05-22 | J-Other | 2.0663 | 2020-05-27 |
| Lotz Christopher L. | officer: VP of Finance, CFO. | 2020-05-22 | J-Other | 2.5405 | 2020-05-27 |
| Lotz Christopher L. | officer: VP of Finance, CFO. | 2020-05-22 | J-Other | 2.0663 | 2020-05-27 |
| Lotz Christopher L. | officer: VP of Finance, CFO. | 2020-05-22 | J-Other | 0 | 2020-05-27 |
| Lotz Christopher L. | officer: VP of Finance, CFO. | 2020-05-22 | J-Other | 2.5405 | 2020-05-27 |
| Kruger Kurt H | director | 2020-05-22 | J-Other | 2.5405 | 2020-05-27 |
| David Richard A. | director | 2020-05-22 | J-Other | 2.5405 | 2020-05-27 |
| Poirier Michael S. | director, officer: Chairman, President and CEO | 2020-05-22 | 0 | 2020-05-27 | |
| Sinha Shishir K. | officer | 2020-05-22 | 0 | 2020-05-27 | |
| Korenberg Matthew E | director: | 2020-05-22 | 0 | 2020-05-27 | |
| Lotz Christopher L. | officer | 2020-05-22 | 0 | 2020-05-27 | |
| Kruger Kurt H | director: | 2020-05-22 | 0 | 2020-05-27 | |
| David Richard A. | director: | 2020-05-22 | 0 | 2020-05-27 | |
| Abdul-Ahad Wajdi | officer | 2020-05-22 | 0 | 2020-05-27 | |
| Ritter Ira E. | director, officer: COB, CSO | 2020-05-18 | A-Award | 0.64 | 2020-05-19 |
| Beck John W | officer: Chief Financial Officer | 2020-05-18 | A-Award | 0.64 | 2020-05-19 |
| Ritter Andrew J | director, officer: CEO and President | 2020-05-18 | A-Award | 0.64 | 2020-05-19 |
| FOEHR MATTHEW W | director | 2020-04-10 | A-Award | 0 | 2020-04-23 |
| FOEHR MATTHEW W | director | 2020-01-21 | C-Conversion | 0 | 2020-04-23 |
| FOEHR MATTHEW W | director | 2020-01-21 | C-Conversion | 1.3 | 2020-04-23 |
| FOEHR MATTHEW W | director | 2020-04-10 | D-Return | 1.3 | 2020-04-23 |
| Doyle Noah | director | 2020-03-12 | S-Sale | 0.22 | 2020-03-16 |
| Ritter Ira E. | director, officer: COB, CSO | 2020-03-04 | S-Sale | 0.3756 | 2020-03-13 |
| Ritter Andrew J | director, officer: CEO and President | 2020-03-04 | S-Sale | 0.3756 | 2020-03-13 |
| Doyle Noah | director | 2020-02-25 | M-Exempt | 0.15 | 2020-02-27 |
| Doyle Noah | director | 2020-02-25 | M-Exempt | 0.15 | 2020-02-27 |
| FOEHR MATTHEW W | director | 2020-01-15 | A-Award | 0.23 | 2020-01-17 |
| Merino William M. | director | 2020-01-15 | A-Award | 0.23 | 2020-01-17 |
| MAIER PAUL V | director | 2020-01-15 | A-Award | 0.23 | 2020-01-17 |
| Doyle Noah | director, 10 percent owner: | 2020-01-15 | A-Award | 0.23 | 2020-01-17 |
| FOEHR MATTHEW W | director | 2019-02-06 | A-Award | 0.6 | 2019-02-08 |
| Doyle Noah | director, 10 percent owner: | 2019-02-06 | A-Award | 0.6 | 2019-02-08 |
| Merino William M. | director | 2019-02-06 | A-Award | 0.6 | 2019-02-08 |
| Merino William M. | director | 2019-02-06 | A-Award | 0.6 | 2019-02-08 |
| MAIER PAUL V | director | 2019-02-06 | A-Award | 0.6 | 2019-02-08 |
| Beck John W | officer: Chief Financial Officer | 2019-02-06 | A-Award | 0.6 | 2019-02-08 |
| Ritter Ira E. | director, officer: COB, CSO | 2019-02-06 | A-Award | 0.6 | 2019-02-08 |
| Ritter Andrew J | director, officer: CEO and President | 2019-02-06 | A-Award | 0.6 | 2019-02-08 |
| FOEHR MATTHEW W | director | 2018-11-05 | P-Purchase | 1.3 | 2018-11-07 |
| FOEHR MATTHEW W | director | 2018-11-05 | P-Purchase | 1.3 | 2018-11-07 |